AlphaYou
Overview
Smart money at a glance
Filings to Oct 12, 2026Net buying: insiders sold $0 and bought $59K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$59K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 12- Open
- $0.97
- 52-wk high
- $2.25
- High
- $1.00
- 52-wk low
- $0.81
- Low
- $0.97
- Prev close
- $0.97
- Mkt cap
- $11.4M
- Volume
- 43.4K
- Fwd P/E
- 0.3x
- Beta
- 0.84
- P/S
- 48.0x
- P/B
- 0.9x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -113.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about PHIO filings
Are insiders buying or selling Phio Pharmaceuticals Corp (PHIO) stock?
Net buying: insiders sold $0 and bought $59K of PHIO stock on the open market in the 90 days to Oct 12, 2026, according to SEC Form 4 filings. The largest was Plott, Ronald Todd (Director), who bought $27K. The latest filing was on Sep 30, 2026.
Which members of Congress have traded PHIO recently?
None. No member of Congress disclosed a PHIO trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this PHIO smart-money data?
This summary uses filings available on Oct 12, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
2 funds hold a position and insiders have been net buying.
What insiders are doing
Buys (3)
- PR
Plott Ronald Todd
$10K
bought
- BP
Bradford Patricia A
$7K
bought
- BR
Bitterman Robert J
$2K
bought
How top traders are positioned
No tracked top-trader positions in PHIO right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings landed in line with what analysts expected.
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Adjusted EPS
-$0.36 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | -$0.36 / -$0.36Yahoo Finance | +0.00% in line | Unavailable | Unavailable |
| Mar 31, 2026 | May 7, 2026 | -$0.34 / -$0.23Yahoo Finance | -44.68% miss | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 5, 2026 | -$0.15 / -$0.47Yahoo Finance | +68.09% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 13, 2025 | -$0.44 / -$0.44Yahoo Finance | +0.00% in line | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 14, 2025 | -$0.45 / -$0.36Alpha Vantage | -25.00% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 15, 2025 | Unavailable | - | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 31, 2025 | -$0.85 / -$1.23Alpha Vantage | +30.89% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 14, 2024 | -$1.54 / -$4.14Alpha Vantage | +62.80% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 12, 2026, in 31 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | $0 | $0 |
| Cost of what it sold | $1.2M | $1.5M | $1.0K | $1.0K |
| Gross profit | -$1.2M | -$1.5M | -$1.0K | -$1.0K |
| What it spent | ||||
| Research and development | $1.2M | $1.5M | $2.8M | $3.1M |
| Sales and admin | $1.3M | $1.1M | $1.4M | $1.2M |
| Other operating costs | -$1.2M | -$1.5M | — | — |
| Total operating expenses | $1.3M | $1.1M | $4.2M | $4.3M |
| What was left | ||||
| Operating profit | -$2.5M | -$2.5M | -$4.2M | -$4.3M |
| Interest on debt | $113.0K | — | — | — |
| Profit before tax | -$2.4M | -$2.4M | -$4.0M | -$4.1M |
| Net profit | -$2.4M | -$2.4M | -$4.0M | -$4.1M |
| EBITDA | -$2.4M | -$2.4M | -$4.0M | -$4.3M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace